AstraZeneca Nolvadex Black Box Added For Breast Cancer Risk Reduction Use

AstraZeneca's Nolvadex black box warns of uterine malignancies, stroke and pulmonary embolism associated with use of the oncologic to reduce the risk of breast cancer, revised labeling says